Biodesix Inc. Reports Q2 2026 Financial Results

What Happened
Biodesix, Inc. announced its financial and operating results for the quarter ended June 30, 2026 by issuing a press release on August 5, 2026. The company filed an 8‑K (Item 2.02) to furnish that press release and incorporated it by reference in the filing.

Key Details

• Filing date: August 5, 2026; reporting quarter: quarter ended June 30, 2026.
• Event reported under Item 2.02: Results of Operations and Financial Condition (press release furnished as Exhibit 99.1).
• The 8‑K was signed by Robin Harper Cowie, Chief Financial Officer, on behalf of Biodesix.
• The press release is attached to the filing (Exhibit 99.1); the filing also includes the Interactive XBRL cover page.

Why It Matters
This 8‑K formally notifies investors that Biodesix has reported its quarterly operating and financial results; those results (revenue, net income/loss, guidance changes, or other metrics) will be detailed in the attached press release. Retail investors should review the press release (Exhibit 99.1) and any related earnings materials for the specific numbers and management commentary to assess the company’s recent performance and short‑term outlook.